SCHEMBL8396166

SCHEMBL8396166

CCN(CCCN(CC)CCN1C(=O)c2cccc3cccc(c23)C1=O)CCN1C(=O)c2cccc3cccc(c23)C1=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.73
HEXA P06865 6/20 0.67
HEXB P07686 6/20 0.67
POLB P06746 2/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
CYP1A2 P05177 1/20 0.67
TNNI3 P19429 1/20 0.67
MAPK1 P28482 1/20 0.67
STAT6 P42226 1/20 0.67
TNNT2 P45379 1/20 0.67
TNNC1 P63316 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
NR1I2 O75469 1/20 0.63
AHR P35869 1/20 0.63
RAD52 P43351 1/20 0.63
RCE1 Q9Y256 1/20 0.63
BCHE P06276 1/20 0.58
ACHE P22303 1/20 0.58
CYP1B1 Q16678 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12672650 0.94 LCK (0.65) LCKHEXAHEXBPOLBMEN1
SCHEMBL6263721 0.93 POLB (0.76) LCKHEXAHEXBPOLBMEN1
SCHEMBL12660268 0.90 LCK (0.61) LCKHEXAHEXBPOLBMEN1
SCHEMBL8393458 0.90 LCK (0.76) LCKHEXAHEXBPOLBMEN1
SCHEMBL1569105 0.90 POLB (0.74) LCKHEXAHEXBPOLBMEN1
SCHEMBL9720969 0.83 ALDH1A1 (0.66) LCKHEXAHEXBPOLBMEN1
SCHEMBL14864819 0.82 HEXA (0.75) LCKHEXAHEXBPOLBMEN1
SCHEMBL8620098 0.82 HEXA (0.75) LCKHEXAHEXBPOLBMEN1
SCHEMBL18017612 0.82 POLB (0.77) LCKHEXAHEXBPOLBMEN1
SCHEMBL14463932 0.82 LCK (0.64) LCKHEXAHEXBPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981753-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed
US-5789418-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1998-08-04 US disclosed
EP-0714387-B1 NEW BIS-NAPHTHALIMIDES FOR THE TREATMENT OF CANCER BASF AG (DE) 1998-05-27 EP disclosed
US-5616589-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1997-04-01 US disclosed
EP-0714387-A1 NEW BIS-NAPHTHALIMIDES FOR THE TREATMENT OF CANCER BASF AKTIENGESELLSCHAFT (DE) 1996-06-05 EP disclosed
WO-1995005365-A1 NEW BIS-NAPHTHALIMIDES FOR THE TREATMENT OF CANCER BASF AKTIENGESELLSCHAFT (DE) 1995-02-23 WO disclosed